PUNE, India, October 24, 2016 /PRNewswire/ --
2016 global age-related macular degeneration market research says market is experiencing a shift toward combination products, using two or more effective treatments. Parallel with the introduction of novel, potent monotherapies for AMD, the market is facing a clear trend toward individualized medicine. The shortcomings of treatment with a single drug can overcome with the use of combination therapy. With AMD, this may mean combination therapy. The need for practical combination therapy exists to address these shortcomings of monotherapy. The goal of combination therapy is to disrupt the multiple stimuli that lead to pathologic cellular proliferation.
Complete report on age-related macular degeneration market spread across 99 pages, analyzing 4 major companies and providing 65 data exhibits now available at http://www.sandlerresearch.org/global-age-related-macular-degeneration-market-2016-2020.html.
This analyst forecast the global age-related macular degeneration market to grow at a CAGR of 7.37% during the period 2016-2020. According to the age-related macular degeneration market report, one of the key drivers for market growth will be increasing reimbursement benefits for AMD drugs. Medicare creates a national reimbursement rate depends on the average selling price of the drug. In this case, the agency pays approximately almost 80% of the ranibizumab and bevacizumab injection, leaving 20% of the drug cost to be co-paid. Medicare Part B (insurance) also covers specific diagnostic tests and treatment of conditions and diseases of the eye, including treatment with specific injected drugs.
The wet AMD segment dominated the age-related macular degeneration market and is expected to reach more than USD 8 billion by 2020. Wet AMD is the most advanced type of AMD and is also referred to as sub-retinal neovascularization degeneration. In age-related wet macular degeneration, the membrane underlying the retina thickens and then breaks to leak blood and fluid. This leakage causes dysfunction and disruption of the retina, forming blind spots in central vision and can even lead to blindness.
The Americas led the age-related macular degeneration market and accounted for more than 51% of the total market shares during 2015. The growing elderly population is one of the primary factors driving this market's growth in the region. Moreover, the presence of patient assistance programs by governmental and non-governmental organizations in the US is also estimated to have a positive impact on the age-related macular degeneration market during the forecast period.
The following companies are the key players in the global age-related macular degeneration market: Bayer HealthCare, F. Hoffmann-La Roche, Novartis, and Regeneron Pharmaceuticals. Other prominent vendors in the market are: Alcon, Allergan, Adverum Biotechnologies, Bausch + Lomb, Gilead Sciences, Iconic Therapeutics, Lpath, Neurotech Pharmaceuticals, Ohr Pharmaceutical, Opthea, Ophthotech, PanOptica, Pfizer, Promedior , QLT, Quark, Resolvyx Pharmaceuticals, RXi Pharmaceuticals, Sagent Pharmaceuticals, Santen Pharmaceuticals, and Sanwa Kagaku Kenkyusho. Order a copy of Global Age-related Macular Degeneration Market 2016-2020 report @ http://www.sandlerresearch.org/purchase?rname=61377.
Global Age-Related Macular Degeneration Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. To calculate the market size, the report considers the revenue generated from the sales of branded, generic, and off-label drugs used for the treatment of AMD.
Another related report is Global Choroidal Neovascularization Market 2016-2020 the market presents significant growth opportunities for vendors. Companies are increasingly forming strategic alliances and engaging in M&A to increase their market share. As the development cost of ophthalmic drugs is high, small biotechnology firms are forming alliances with big pharmaceutical companies for product development. Browse complete report @ http://www.sandlerresearch.org/global-choroidal-neovascularization-market-2016-2020.html.
Explore other new reports on Pharmaceutical Market @ http://www.sandlerresearch.org/market-research/pharmaceutical .
SandlerResearch.org is your go-to source for all market research needs. Our database includes thousands of market research reports from over multiple leading global publishers & in-depth market research studies of over several micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.
2nd Floor, Metropole
Next to Inox Theatre
Bund Garden Road
Pune - 411001
Connect with Us:
G+ / Google Plus: https://plus.google.com/106598308303011242341/posts
SOURCE Sandler Research